A novel variable number of tandem repeats (VNTR) polymorphism containing Sp1 binding elements in the promoter of XRCC5 is a risk factor for human bladder cancer

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 638, Issue 1-2, 2008, Pages 26-36

  Wang, Shouyu ^a   Wang, Meilin ^a   Yin, Shiwei ^a   Fu, Guangbo ^a   Li, Chunping ^a   Chen, Rui ^a   Li, Aiping ^a   Zhou, Jianwei ^a   Zhang, Zhengdong ^a   Liu, Qizhan ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Bladder cancer; Genetic susceptibility; Transcription activity; XRCC5

Indexed keywords

CARRIER PROTEIN; PROTEIN XRCC5; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; BINDING AFFINITY; BLADDER CANCER; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; VARIABLE NUMBER OF TANDEM REPEAT;

AGED; BASE SEQUENCE; DNA HELICASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RISK FACTORS; SP1 TRANSCRIPTION FACTOR; URINARY BLADDER NEOPLASMS;

EID: 37849015943     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2007.08.011     Document Type: Article

References (37)

1. Parkin D.M. International variation. Oncogene 23 (2004) 6329-6340
2. Cohen S.M., Shirai T., and Steineck G. Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J. Urol. Nephrol. Suppl. (2000) 105-115
3. Vineis P., Talaska G., Malaveille C., Bartsch H., Martone T., Sithisarankul P., and Strickland P. DNA adducts in urothelial cells: relationship with biomarkers of exposure to arylamines and polycyclic aromatic hydrocarbons from tobacco smoke. Int. J. Cancer 65 (1996) 314-316
4. Miyajima A., Nakashima J., Yoshioka K., Tachibana M., Tazaki H., and Murai M. Role of reactive oxygen species in cis-dichlorodiammineplatinum-induced cytotoxicity on bladder cancer cells. Br. J. Cancer 76 (1997) 206-210
5. Hoeijmakers J.H. Genome maintenance mechanisms for preventing cancer. Nature 411 (2001) 366-374
6. Lindahl T., and Wood R.D. Quality control by DNA repair. Science 286 (1999) 1897-1905
7. Haber J.E. Partners and pathways repairing a double-strand break. Trends Genet. 16 (2000) 259-264
8. Takata M., Sasaki M.S., Sonoda E., Morrison C., Hashimoto M., Utsumi H., Yamaguchi-Iwai Y., Shinohara A., and Takeda S. Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO J. 17 (1998) 5497-5508
9. van Gent D.C., Hoeijmakers J.H., and Kanaar R. Chromosomal stability and the DNA double-stranded break connection. Nat. Rev. Genet. 2 (2001) 196-206
10. Hopfner K.P., Putnam C.D., and Tainer J.A. DNA double-strand break repair from head to tail. Curr. Opin. Struct. Biol. 12 (2002) 115-122
11. Cai Q.Q., Plet A., Imbert J., Lafage-Pochitaloff M., Cerdan C., and Blanchard J.M. Chromosomal location and expression of the genes coding for Ku p70 and p80 in human cell lines and normal tissues. Cytogenet. Cell Genet. 65 (1994) 221-227
12. Gu Y., Seidl K.J., Rathbun G.A., Zhu C., Manis J.P., van der Stoep N., Davidson L., Cheng H.L., Sekiguchi J.M., Frank K., Stanhope-Baker P., Schlissel M.S., Roth D.B., and Alt F.W. Growth retardation and leaky SCID phenotype of Ku70-deficient mice. Immunity 7 (1997) 653-665
13. Khanna K.K., and Jackson S.P. DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet. 27 (2001) 247-254
14. Stronati L., Gensabella G., Lamberti C., Barattini P., Frasca D., Tanzarella C., Giacobini S., Toscano M.G., Santacroce C., and Danesi D.T. Expression and DNA binding activity of the Ku heterodimer in bladder carcinoma. Cancer 92 (2001) 2484-2492
15. Lim J.W., Kim H., and Kim K.H. Expression of Ku70 and Ku80 mediated by NF-kappa B and cyclooxygenase-2 is related to proliferation of human gastric cancer cells. J. Biol. Chem. 277 (2002) 46093-46100
16. Pucci S., Mazzarelli P., Rabitti C., Giai M., Gallucci M., Flammia G., Alcini A., Altomare V., and Fazio V.M. Tumor specific modulation of KU70/80 DNA binding activity in breast and bladder human tumor biopsies. Oncogene 20 (2001) 739-747
17. Ludwig D.L., Chen F., Peterson S.R., Nussenzweig A., Li G.C., and Chen D.J. Ku80 gene expression is Sp1-dependent and sensitive to CpG methylation within a novel cis element. Gene 199 (1997) 181-194
18. Li C., Wu W., Liu J., Qian L., Li A., Yang K., Wei Q., Zhou J., and Zhang Z. Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis. Pharmacogenet. Genomics 16 (2006) 245-251
19. Hao B., Miao X., Li Y., Zhang X., Sun T., Liang G., Zhao Y., Zhou Y., Wang H., Chen X., Zhang L., Tan W., Wei Q., Lin D., and He F. A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer. Oncogene 25 (2006) 3613-3620
20. Shou Y., Baron S., and Poncz M. An Sp1-binding silencer element is a critical negative regulator of the megakaryocyte-specific alphaIIb gene. J. Biol. Chem. 273 (1998) 5716-5726
21. Won J., Yim J., and Kim T.K. Sp1 and Sp3 recruit histone deacetylase to repress transcription of human telomerase reverse transcriptase (hTERT) promoter in normal human somatic cells. J. Biol. Chem. 277 (2002) 38230-38238
22. Dean G., Young D.A., Edwards D.R., and Clark I.M. The human tissue inhibitor of metalloproteinases (TIMP)-1 gene contains repressive elements within the promoter and intron 1. J. Biol. Chem. 275 (2000) 32664-32671
23. Tonotsuka N., Hosoi Y., Miyazaki S., Miyata G., Sugawara K., Mori T., Ouchi N., Satomi S., Matsumoto Y., Nakagawa K., Miyagawa K., and Ono T. Heterogeneous expression of DNA-dependent protein kinase in esophageal cancer and normal epithelium. Int. J. Mol. Med. 18 (2006) 441-447
24. Hosoi Y., Watanabe T., Nakagawa K., Matsumoto Y., Enomoto A., Morita A., Nagawa H., and Suzuki N. Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer. Int. J. Oncol. 25 (2004) 461-468
25. Parrella P., Mazzarelli P., Signori E., Perrone G., Marangi G.F., Rabitti C., Delfino M., Prencipe M., Gallo A.P., Rinaldi M., Fabbrocini G., Delfino S., Persichetti P., and Fazio V.M. DNA binding activity and ku70/80 heterodimer expression in human non-melanoma-skin cancer. J. Clin. Pathol. (2006)
26. Chang H.W., Kim S.Y., Yi S.L., Son S.H., Song D.Y., Moon S.Y., Kim J.H., Choi E.K., Ahn S.D., Shin S.S., Lee K.K., and Lee S.W. Expression of Ku80 correlates with sensitivities to radiation in cancer cell lines of the head and neck. Oral Oncol. (2006)
27. Klein A., Miera O., Bauer O., Golfier S., and Schriever F. Chemosensitivity of B cell chronic lymphocytic leukemia and correlated expression of proteins regulating apoptosis, cell cycle and DNA repair. Leukemia 14 (2000) 40-46
28. Nakamura Y., Koyama K., and Matsushima M. VNTR (variable number of tandem repeat) sequences as transcriptional, translational, or functional regulators. J. Hum. Genet. 43 (1998) 149-152
29. Tsuge M., Hamamoto R., Silva F.P., Ohnishi Y., Chayama K., Kamatani N., Furukawa Y., and Nakamura Y. A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5′-flanking region of SMYD3 is a risk factor for human cancers. Nat. Genet. 37 (2005) 1104-1107
30. Contente A., Dittmer A., Koch M.C., Roth J., and Dobbelstein M. A polymorphic microsatellite that mediates induction of PIG3 by p53. Nat. Genet. 30 (2002) 315-320
31. Horie N., Aiba H., Oguro K., Hojo H., and Takeishi K. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5′-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct. Funct. 20 (1995) 191-197
32. Kawakami K., Omura K., Kanehira E., and Watanabe Y. Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers. Anticancer Res. 19 (1999) 3249-3252
33. Yawata A., Kim S.R., Miyajima A., Kubo T., Ishida S., Saito Y., Nakajima Y., Katori N., Matsumoto Y., Fukuoka M., Ohno Y., Ozawa S., and Sawada J. Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents. Cancer Chemother. Pharmacol. 56 (2005) 465-472
34. Djian P. Evolution of simple repeats in DNA and their relation to human disease. Cell 94 (1998) 155-160
35. Gorgoulis V.G., Liloglou T., Sigala F., Korkolis D., Yannoukakos D., Papalambros E., Asimacopoulos P.J., Papavassiliou A.G., and Kotsinas A. Absence of association with cancer risk and low frequency of alterations at a p53 responsive PIG3 gene polymorphism in breast and lung carcinomas. Mutat. Res. 556 (2004) 143-150
36. Zhang Z., Xu Y., Zhou J., Wang X., Wang L., Hu X., Guo J., Wei Q., and Shen H. Polymorphisms of thymidylate synthase in the 5′- and 3′-untranslated regions associated with risk of gastric cancer in South China: a case-control analysis. Carcinogenesis 26 (2005) 1764-1769
37. Zhang Z., Shi Q., Sturgis E.M., Spitz M.R., Hong W.K., and Wei Q. Thymidylate synthase 5′- and 3′-untranslated region polymorphisms associated with risk and progression of squamous cell carcinoma of the head and neck. Clin. Cancer Res. 10 (2004) 7903-7910